This leads to a condition known as Gray baby syndrome.

Intravenous chloramphenicol use has been associated with the so-called gray baby syndrome.

Two pathophysiologic mechanisms are thought to play a role in the development of gray baby syndrome after exposure to the anti-microbial drug chloramphenicol.

As an example, the agency said that many infants died of "gray baby syndrome" in the 1950's because an antibiotic, chloramphenicol, was not adequately tested in children.

Gray baby syndrome (also termed Gray or Grey syndrome) is a rare but serious side effect that occurs in newborn infants (especially premature babies) following the intravenous administration of the antimicrobial chloramphenicol.

Others (e.g. Grey Syndrome) have not yet made their way into the DSM23-truth be told, I invented a couple- but are nonetheless based on actual experimental evidence.

Gray baby syndrome (also termed Gray or Grey syndrome) is a rare but serious side effect that occurs in newborn infants (especially premature babies) following the intravenous administration of the antimicrobial chloramphenicol.